1 Medical Village DrEdgewood, KY 41017
Fax+1 859-301-4008
Overview of Dr. Flora
Dr. Daniel Flora is an oncologist based in Edgewood, KY, specializing in breast cancer, melanoma, and complementary and integrative medicine with a focus on clinical pharmacology. He earned his medical degree from Wright State University Boonshoft School of Medicine in 2008. Dr. Flora has contributed to several publications, including research on T-cell immune checkpoint inhibition in breast cancer and the impact of COVID-19 on cancer patients. His work, published in esteemed journals such as JAMA Oncology, has been cited numerous times. He has received multiple CMS Meaningful Use Stage 1 and 2 Certifications from Epic Systems Corporation between 2015 and 2017.
Education & Training
Wright State University Boonshoft School of MedicineClass of 2008
Certifications & Licensure
IN State Medical License 2014 - 2027
KY State Medical License 2014 - 2027
OH State Medical License 2003 - 2017
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
Publications & Presentations
PubMed
- 1 citationsLongitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma.George Ansstas, Karam Khaddour, Sumedha Sudhaman, Karen Lin, Griffin L Budde
Clinical Cancer Research. 2026-04-15 - 11 citationsT-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrol...Harry D Bear, Xiaoyan Deng, Dipankar Bandyopadhyay, Michael Idowu, Taylor M Jenkins
Journal for Immunotherapy of Cancer. 2025-02-27 - Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis.Amit A Kulkarni, Cassandra Hennessy, Grace Wilson, Vidhyalakshmi Ramesh, Clara Hwang
Clinical Lung Cancer. 2024-07-01
Press Mentions
Blind Spots in Cancer CareMay 23rd, 2026- What Happens When You Don't Die on Time?April 6th, 2026
- The Trade-Offs of Leaving Pharmacy for MedicineMarch 24th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
